Clinical Trials Browser

Phase 2 × Dendritic Cell Sarcoma, Interdigitating × zanubrutinib × Clear all

NCT06846463 2026-01-23

Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+

Phase 2 Recruiting

LymphoidSarcoma

Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating